BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23393326)

  • 1. Prognostic impact of fascin-1 (FSCN1) in epithelial ovarian cancer.
    Hanker LC; Karn T; Holtrich U; Graeser M; Becker S; Reinhard J; Ruckhäberle E; Gevensleben H; Rody A
    Anticancer Res; 2013 Feb; 33(2):371-7. PubMed ID: 23393326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic relevance of fascin expression in human gastric carcinoma.
    Hashimoto Y; Shimada Y; Kawamura J; Yamasaki S; Imamura M
    Oncology; 2004; 67(3-4):262-70. PubMed ID: 15557788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
    Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
    Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fascin expression in human epithelial tumors and its clinical significance].
    Gao X; Wu DH
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):953-5. PubMed ID: 18583236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fascin-1 expression as stratification marker in borderline epithelial tumours of the ovary.
    El-Balat A; Arsenic R; Sänger N; Karn T; Becker S; Holtrich U; Engels K
    J Clin Pathol; 2016 Feb; 69(2):142-8. PubMed ID: 26362828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer.
    Zhang J; Tang L; Chen Y; Duan Z; Xiao L; Li W; Liu X; Shen L
    Hum Pathol; 2015 Sep; 46(9):1331-40. PubMed ID: 26193797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fascin expression is related to poor survival in gastric cancer.
    Kim SJ; Kim DC; Kim MC; Jung GJ; Kim KH; Jang JS; Kwon HC; Kim YM; Jeong JS
    Pathol Int; 2012 Dec; 62(12):777-84. PubMed ID: 23252866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CXCR4 indicates poor prognosis in patients with clear cell carcinoma of the ovary.
    Sekiya R; Kajiyama H; Sakai K; Umezu T; Mizuno M; Shibata K; Yamamoto E; Fujiwara S; Nagasaka T; Kikkawa F
    Hum Pathol; 2012 Jun; 43(6):904-10. PubMed ID: 22169254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fascin overexpression correlates with positive thrombospondin-1 and syndecan-1 expressions and a more aggressive clinical course in patients with gallbladder cancer.
    Roh YH; Kim YH; Choi HJ; Lee KE; Roh MS
    J Hepatobiliary Pancreat Surg; 2009; 16(3):315-21. PubMed ID: 19259612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of IEX-1 expression in ovarian carcinoma.
    Han L; Geng L; Liu X; Shi H; He W; Wu MX
    Ultrastruct Pathol; 2011 Dec; 35(6):260-6. PubMed ID: 22085302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of podoplanin in epithelial ovarian carcinomas and its potential as a marker for clear cell adenocarcinoma.
    Oe S; Hasegawa K; Nagase S; Kato R; Torii Y; Udagawa Y
    Int J Gynecol Pathol; 2010 Sep; 29(5):405-10. PubMed ID: 20736762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of cortactin and fascin are effective markers for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas.
    Li X; Zheng H; Hara T; Takahashi H; Masuda S; Wang Z; Yang X; Guan Y; Takano Y
    Int J Oncol; 2008 Jul; 33(1):69-79. PubMed ID: 18575752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer.
    Li T; Xue H; Guo Y; Guo K
    Oncol Rep; 2014 Apr; 31(4):1825-31. PubMed ID: 24573179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated expression of MAC30 predicts lymph node metastasis and unfavorable prognosis in patients with epithelial ovarian cancer.
    Yang S; Li H; Liu Y; Ning X; Meng F; Xiao M; Wang D; Lou G; Zhang Y
    Med Oncol; 2013 Mar; 30(1):324. PubMed ID: 23254963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of DNA damage checkpoint protein Hus1 in epithelial ovarian tumors correlates with prognostic markers.
    de la Torre J; Gil-Moreno A; García A; Rojo F; Xercavins J; Salido E; Freire R
    Int J Gynecol Pathol; 2008 Jan; 27(1):24-32. PubMed ID: 18156970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of ASAP1 is associated with poor prognosis in epithelial ovarian cancer.
    Hou T; Yang C; Tong C; Zhang H; Xiao J; Li J
    Int J Clin Exp Pathol; 2014; 7(1):280-7. PubMed ID: 24427349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of fascin expression in advanced poorly differentiated serous ovarian cancer.
    Daponte A; Kostopoulou E; Papandreou CN; Daliani DD; Minas M; Koukoulis G; Messinis IE
    Anticancer Res; 2008; 28(3B):1905-10. PubMed ID: 18630479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma.
    Srivatsa PJ; Cliby WA; Keeney GL; Dodson MK; Suman VJ; Roche PC; Podratz KC
    Gynecol Oncol; 1996 Mar; 60(3):363-72. PubMed ID: 8774640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic factors of epithelial ovarian cancer in young women].
    Zhang R; Wu LY; Zhang WH; Li HJ; Li SM; Liu LY
    Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):264-7. PubMed ID: 12839691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
    Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
    Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.